312 related articles for article (PubMed ID: 23869238)
1. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
[TBL] [Abstract][Full Text] [Related]
2. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
[TBL] [Abstract][Full Text] [Related]
3. Lasiodin inhibits proliferation of human nasopharyngeal carcinoma cells by simultaneous modulation of the Apaf-1/caspase, AKT/MAPK and COX-2/NF-κB signaling pathways.
Lin L; Deng W; Tian Y; Chen W; Wang J; Fu L; Shi D; Zhao M; Luo W
PLoS One; 2014; 9(5):e97799. PubMed ID: 24845412
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells.
Wang J; Liu L; Qiu H; Zhang X; Guo W; Chen W; Tian Y; Fu L; Shi D; Cheng J; Huang W; Deng W
PLoS One; 2013; 8(5):e63872. PubMed ID: 23737956
[TBL] [Abstract][Full Text] [Related]
5. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells.
Ren KW; Li YH; Wu G; Ren JZ; Lu HB; Li ZM; Han XW
Int J Oncol; 2017 Apr; 50(4):1299-1311. PubMed ID: 28259895
[TBL] [Abstract][Full Text] [Related]
6. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
7. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
9. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
12. Isocudraxanthone K induces growth inhibition and apoptosis in oral cancer cells via hypoxia inducible factor-1α.
Shin MR; Lee HJ; Kang SK; Auh QS; Lee YM; Kim YC; Kim EC
Biomed Res Int; 2014; 2014():934691. PubMed ID: 25105148
[TBL] [Abstract][Full Text] [Related]
13. Effusanin E suppresses nasopharyngeal carcinoma cell growth by inhibiting NF-κB and COX-2 signaling.
Zhuang M; Zhao M; Qiu H; Shi D; Wang J; Tian Y; Lin L; Deng W
PLoS One; 2014; 9(10):e109951. PubMed ID: 25333664
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors.
Mahfouz N; Tahtouh R; Alaaeddine N; El Hajj J; Sarkis R; Hachem R; Raad I; Hilal G
PLoS One; 2017; 12(6):e0179202. PubMed ID: 28594907
[TBL] [Abstract][Full Text] [Related]
15. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
16. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.
Mahata S; Bharti AC; Shukla S; Tyagi A; Husain SA; Das BC
Mol Cancer; 2011 Apr; 10():39. PubMed ID: 21496227
[TBL] [Abstract][Full Text] [Related]
17. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
[TBL] [Abstract][Full Text] [Related]
18. 8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo.
Xiao Y; Tian C; Huang T; Han B; Wang M; Ma H; Li Z; Ye X; Li X
Life Sci; 2018 Jan; 192():259-269. PubMed ID: 29138118
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]